CURX vs KEY · $8.9M cap vs P/E 13, rev $3.92B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
KeyCorp (KEY) is a banks - regional company listed on US.
CURX does not have a complete income-statement cache yet.
Latest reported KEY revenue for 2026-06-30 was $3.92B. Net income was $1.03B. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
CURX currently screens at market cap $8.9M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the CURX and KEY stock pages for the full models.
Not investment advice.